Ventripoint Diagnostics Ltd.

DB:5V7 Stock Report

Market Cap: €26.7m

Ventripoint Diagnostics Past Earnings Performance

Past criteria checks 0/6

Ventripoint Diagnostics's earnings have been declining at an average annual rate of -15.1%, while the Medical Equipment industry saw earnings growing at 2% annually. Revenues have been declining at an average rate of 15.8% per year.

Key information

-15.1%

Earnings growth rate

13.0%

EPS growth rate

Medical Equipment Industry Growth4.3%
Revenue growth rate-15.8%
Return on equity-2,568.2%
Net Margin-9,905.7%
Last Earnings Update31 Dec 2023

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown
Beta

How Ventripoint Diagnostics makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

DB:5V7 Revenue, expenses and earnings (CAD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 230-541
30 Sep 230-541
30 Jun 230-541
31 Mar 230-541
31 Dec 220-541
30 Sep 220-541
30 Jun 220-441
31 Mar 220-330
31 Dec 210-430
30 Sep 210-330
30 Jun 210-330
31 Mar 210-220
31 Dec 200-220
30 Sep 200-220
30 Jun 200-221
31 Mar 200-321
31 Dec 190-321
30 Sep 190-421
30 Jun 190-321
31 Mar 190-331
31 Dec 180-221
30 Sep 180-321
30 Jun 180-331
31 Mar 180021
31 Dec 170-421
30 Sep 170-221
30 Jun 170-311
31 Mar 170-611
31 Dec 160-311
30 Sep 160-211
30 Jun 160-211
31 Mar 160-211
31 Dec 150-211
30 Sep 150-210
30 Jun 150-220
31 Mar 150-221
31 Dec 140-211
30 Sep 140-111
30 Jun 140-211
31 Mar 140-211
31 Dec 130-222
30 Sep 130-422
30 Jun 130-323

Quality Earnings: 5V7 is currently unprofitable.

Growing Profit Margin: 5V7 is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 5V7 is unprofitable, and losses have increased over the past 5 years at a rate of 15.1% per year.

Accelerating Growth: Unable to compare 5V7's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 5V7 is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (-9.8%).


Return on Equity

High ROE: 5V7 has a negative Return on Equity (-2568.15%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.